Covered stents in iliac artery occlusive disease: what is the evidence?

Bibombe P. Mwipatayi, E. Suthers, S. D. D. Thomas, Nish Altaf

    Research output: Contribution to journalReview articlepeer-review

    3 Citations (Scopus)


    The last two decades have seen a revolution in the treatment of aortoiliac occlusive disease (AIOD). Acceptable safety and durability outcomes have now been realized with endovascular treatments, which is increasingly finding a place in the treatment of AIOD. Evolution of stent technologies and endovascular techniques is seeing an expansion of MOD lesions indicated for primary endovascular treatment. The literature evidence basis is continuously evolving, and questions remain as to the optimal form of vessel treatment. Covered stents have been increasingly promoted for their long-term durability, particularly in extensive, challenging MOD lesions. Here, we explore the seminal evidence basis for covered stents in the treatment of AIOD, and aim to provide a sound evidence based argument for their use.
    Original languageEnglish
    Pages (from-to)336-342
    Number of pages7
    JournalThe Journal of Cardiovascular Surgery
    Issue number3
    Publication statusPublished - Jun 2016


    Dive into the research topics of 'Covered stents in iliac artery occlusive disease: what is the evidence?'. Together they form a unique fingerprint.

    Cite this